Cargando…
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
IMPORTANCE: List prices set by manufacturers for brand-name prescription drugs in the US have been increasing faster than inflation, although confidential manufacturer rebates offset some of these increases. Most commercially insured patients pay at least some out-of-pocket costs for prescription dr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097497/ https://www.ncbi.nlm.nih.gov/pubmed/33944925 http://dx.doi.org/10.1001/jamanetworkopen.2021.8816 |